Connect with us

U.S. FDA advisory panel to discuss COVID-19 vaccine boosters on Sept. 17

HBS Reporting

U.S. FDA advisory panel to discuss COVID-19 vaccine boosters on Sept. 17

U.S. FDA advisory panel to discuss COVID-19 vaccine boosters on Sept. 17

(Reuters) – The U.S. Food and Drug Administration said on Wednesday its outside advisers will meet on Sept. 17 to discuss additional doses of COVID-19 vaccines and specifically Pfizer Inc and partner BioNTech’s application for the use of a booster vaccine dose.

Continue Reading
You may also like...
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More in HBS Reporting